Quick Summary:
In an ever-evolving livestock industry, keeping abreast with the market dynamism is pivotal. The Global Foot and Mouth Disease (FMD) Vaccine Market report offers a thorough and analytic explanation of the space, presenting crucial data to drive optimized decision-making. The report shows that the FMD Vaccine market, valued at US$2.2 Billion in 2022, is set to grow significantly, reaching an anticipated worth of US$5.6 Billion by 2030 – a growth trajectory presenting substantial investment opportunities.
Detailed analysis of key geographic markets, such as the U.S., China, Japan, Canada, and Germany, provides insights into regional trends, aiding in your strategic planning. The report also highlights prominent competitors, facilitating an understanding of the competition. With special coverage on a variety of topics, and complimentary updates for a year, this report offers fundamental tools needed for sustaining, and prospering in the FMD Vaccine market. Equip your business to navigate the future successfully by gaining an essential view of the market landscape.
Global Foot and Mouth Disease (FMD) Vaccine Market to Reach $5.6 Billion by 2030
The global market for Foot and Mouth Disease (FMD) Vaccine estimated at US$2.2 Billion in the year 2022, is projected to reach a revised size of US$5.6 Billion by 2030, growing at a CAGR of 12.5% over the analysis period 2022-2030. Conventional Vaccines, one of the segments analyzed in the report, is projected to record 10.9% CAGR and reach US$3.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Emergency Vaccines segment is readjusted to a revised 15.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $592.8 Million, While China is Forecast to Grow at 18.4% CAGR
The Foot and Mouth Disease (FMD) Vaccine market in the U.S. is estimated at US$592.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 18.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 11.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.Select Competitors (Total 42 Featured) -
- Agrovet Co
- Beohringer Ingelheim
- Biogénesis Bagó
- Brilliant Bio Pharma Ltd.
- Ceva Santé Animale
- Empresa Colombiana de Productos Veterinarios S.A. VECOL S.A.
- FMD Center
- Godrej Agrovet Limited
- Indian Immunologicals Limited
- Limor de Colombia
- Merck Animal Health
- Merial S. A. S.
- Vecol SA
- Vetal Animal Health Products
- Veterinary Serum and Vaccine Research Institute
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Foot and Mouth Disease (FMD) Vaccine?
What is the growth rate of the Global Market for Foot and Mouth Disease (FMD) Vaccine?
What is the forecasted size of the Global Market for Foot and Mouth Disease (FMD) Vaccine?
Who are the key companies in the Global Market for Foot and Mouth Disease (FMD) Vaccine?
| Report Attribute | Details |
|---|---|
| No. of Pages | 93 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 2.2 Billion |
| Forecasted Market Value ( USD | $ 5.6 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Agrovet Co
- Beohringer Ingelheim
- Biogénesis Bagó
- Brilliant Bio Pharma Ltd.
- Ceva Santé Animale
- Empresa Colombiana de Productos Veterinarios S.A. VECOL S.A.
- FMD Center
- Godrej Agrovet Limited
- Indian Immunologicals Limited
- Limor de Colombia
- Merck Animal Health
- Merial S. A. S.
- Vecol SA
- Vetal Animal Health Products
- Veterinary Serum and Vaccine Research Institute
